Sort by
Refine Your Search
-
at their genetic source by 'interfering' with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality. Our
-
on the design, development, and realization of future communications technologies. You will be part of the team and contribute to ongoing developments in theory, algorithms and translation to practice in
-
diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by “interfering” with mRNA that cause
Searches related to genetic algorithm
Enter an email to receive alerts for genetic-algorithm positions